“Increasing Preference for Minimally Invasive Procedures”
- Minimally invasive procedures such as angioplasty and stent placement are increasingly preferred over traditional coronary artery bypass surgeries, offering quicker recovery and fewer complications. Hospitals such as the Cleveland Clinic have adopted these methods for their patient-friendly outcomes, with angioplasty being one of the most common procedures performed globally
- Procedures such as angioplasty are now done through small punctures, reducing the need for large incisions and lengthy hospital stays
- For instance, patients undergoing angioplasty at the Mayo Clinic are often discharged within 24 hours, significantly reducing recovery times compared to traditional surgery, which may require a hospital stay of several days
- The development of drug-eluting stents, which release medication to prevent artery re-narrowing, has enhanced the effectiveness of minimally invasive procedures. According to a study by the National Institutes of Health, these stents have significantly lowered the risk of restenosis, improving long-term patient outcomes
- Minimally invasive procedures come with a lower risk of infections and other complications. A study published in the Journal of the American College of Cardiology highlighted that patient who underwent percutaneous coronary interventions experienced fewer complications than those who had traditional open-heart surgery
- Minimally invasive approaches lead to less pain and a faster return to normal activities, contributing to an improved patient experience
- For instance, patients at Johns Hopkins Hospital who undergo angioplasty and stenting often return to work within a few days, enhancing overall quality of life after the procedure
Frequently Asked Questions
The increasing preference for minimally invasive procedures, is emerging as a pivotal trend driving the global coronary artery disease market.
The major factors driving the growth of the coronary artery disease market is increasing prevalence of heart disease globally.
The primary challenges include high cost of treatments and procedures.
The medication segment is expected to dominate the global coronary artery disease market holding a major market share in 2025, due to significant demand for both medication and surgical interventions.
Asia-Pacific is the fastest growing region in the global coronary artery disease market due rapid urbanization, an aging population, rising healthcare awareness, and increasing lifestyle changes leading to more heart disease cases in countries such as China and India.
